Koers Marapharm Ventures Inc Canadian Securities Exchange
Aandelen
CA56575M1086
Gezondheidszorgvoorzieningen & -diensten
Omzet 2020 | 2,27 3,09 2,09 | Omzet 2021 | 3,15 4,29 2,9 | Marktkapitalisatie | 10,06 mln. 13,71 mln. 9,26 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2020 | -40 mln. -54,52 mln. -36,83 mln. | Nettowinst (verlies) 2021 | -8 mln. -10,9 mln. -7,37 mln. | EV/omzet 2020 | 13.592.488 x |
Nettoschuld 2020 | 5,3 mln. 7,23 mln. 4,88 mln. | Nettoschuld 2021 | 13,31 mln. 18,14 mln. 12,25 mln. | EV/omzet 2021 | 7.417.546 x |
K/w-verhouding 2020 |
-0,45
x | K/w-verhouding 2021 |
-1,08
x | Werknemers | - |
Dividendrendement 2020 * |
-
| Dividendrendement 2021 |
-
| Vrij verhandelbaar | 71,26% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Paul Searle
IRO | Public Communications Contact | - | - |
James O’Sullivan
SEC | Corporate Secretary | - | 18-11-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Scott R. Berman
BRD | Director/Board Member | - | - |
Dylan Rexing
BRD | Director/Board Member | - | 08-10-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-.--% | 339 mln. | |
+48,56% | 299 mln. | |
+25,77% | 279 mln. | |
+51,16% | 206 mln. | |
+161,28% | 154 mln. | |
+48,02% | 132 mln. | |
-42,86% | 122 mln. | |
-40,82% | 119 mln. | |
+7,69% | 118 mln. |